These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16466024)

  • 1. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
    Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
    Fan E; Shi W; Lowary TL
    J Org Chem; 2007 Apr; 72(8):2917-28. PubMed ID: 17373847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
    Miklán Z; Orbán E; Csík G; Schlosser G; Magyar A; Hudecz F
    Biopolymers; 2009; 92(6):489-501. PubMed ID: 19521976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D; Khare A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.
    Renneberg B; Li YM; Laatsch H; Fiebig HH
    Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting anthracycline scaffold for designing DNA-targeting agents.
    Priebe W; Fokt I; Przewloka T; Chaires JB; Portugal J; Trent JO
    Methods Enzymol; 2001; 340():529-55. PubMed ID: 11494869
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystal structures and spectroscopic properties of ester amide and diamide of squaric acid with prolinamide.
    Kolev T; Seidel RW; Mayer-Figge H; Spiteller M; Sheldrick WS; Koleva BB
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):502-9. PubMed ID: 19101193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antitumor activity of new analogs of anthracycline antibiotics modified by aglycon].
    Olsuf'eva EN
    Bioorg Khim; 1990 Nov; 16(11):1445-64. PubMed ID: 2096823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies.
    Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pK
    Matyjaszczyk K; Kolonko M; Gonciarz-Dytman A; Oszczapowicz I; Łukawska M; Jawień W; Chlopicki S; Walczak M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():44-52. PubMed ID: 28599260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
    Urbahns K; Härter M; Albers M; Schmidt D; Stelte-Ludwig B; Brüggemeier U; Vaupel A; Keldenich J; Lustig K; Tsujishita H; Gerdes C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6151-4. PubMed ID: 17910915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anthracyclines in the era of targeted therapy.
    Cortés-Funes H; Coronado C
    Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the tetracyclic core of anthracycline antibiotics by an intramolecular dehydro Diels-Alder approach.
    Rodríguez D; Castedo L; Domínguez D; Saá C
    Org Lett; 2003 Aug; 5(17):3119-21. PubMed ID: 12916996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiproliferative effects of a 4'-morpholino-9-methyl anthracycline.
    Nafziger J; Averland G; Bertounesque E; Gaudel G; Monneret C
    J Antibiot (Tokyo); 1995 Oct; 48(10):1185-7. PubMed ID: 7490233
    [No Abstract]   [Full Text] [Related]  

  • 19. Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases.
    Xie J; Comeau AB; Seto CT
    Org Lett; 2004 Jan; 6(1):83-6. PubMed ID: 14703356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Be squared: expanding the horizon of squaric acid-mediated conjugations.
    Wurm FR; Klok HA
    Chem Soc Rev; 2013 Nov; 42(21):8220-36. PubMed ID: 23873344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.